Нур-Султан, 2019
жүктеу/скачать 2,5 Mb. Pdf көрінісі
|
руководство ХСН
| Диспансерное наблюдение
Пациенты с ХСН подлежат диспансерному наблюдению, не реже 1 раза в 2 месяца или чаще, если это определяется клинической ситуацией или ухудшением течения основного заболевания. Пациенты, перенесшие трансплантацию сердца, подлежат пожизненному диспансерному наблюдению, не реже 1 раза в месяц. Список литературы: 1. Chronic heart failure in adults: diagnosis and management. NICE (National Institute for Health and care Excellence) guideline, 2018. – P 1-38. 2. Ponikowski P., Voors A.A., Anker S.D. et al. Guidelines for the diagnosis and treatment Acute and Chronic Heart Failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC // Eur Heart J. 2016. – P 1-85. 3. Yancy C.W., Jessup M., Masoudi F.A. et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America // Circulation 2017. – Р 137-161. 4. Konstam M.A., Kiernan M.S., Bernstein D. et al. Evaluation and Management of Right-Sided Heart Failure. A Scientific Statement From the American Heart Association Endorsed by the Heart Failure Society of America and International Society for Heart and Lung Transplantation // Circulation 2018. – P 1-47. 5. Bayes-Genis А., de Antonio M., Vila J. et al. Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification // J Am Coll Cardiol 2014. - №63. – Р 158–66. 6. Aleksova A., Paldino A., Beltrami A. et al. Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failureand Acute Coronary Syndrome—There is Meat on the Bone // J. Clin. Med. 2019. - №8. - Р 270 7. Choudhary R., Shah K., Maisel A. Biomarkers in acute heart failure. The ESC Textbook of Intensive and Acute Cardiovascular Care (2 ed.). 2018 February. 8. Meijers W. C., Januzzi J.L., Defilippi, C. et al. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure:A pooled analysis of 3 clinical trials // Am Heart J. 2014 Jun. – 167(6). – Р 853-60. e4 133 9. Imran T.F., Shin H.J., Mathenge N. et al. Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population // Am J Cardiol. 2017 Jan 1. – 119(1). – Р 57-64. 10. Januzzi J.L., Mebazaa A., Di Somma S. ST2 and Prognosis in Acutely Decompensated Heart Failure:The International ST2 Consensus Panel. // Am. J. Cardiol 2015. – 115. –Р 26–31. 11. Kormos R.L., Cowger J., Pagani F.D. et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships // Ann ThoracSurg 2019. - 107(2). – Р 341-353. 12. Bourque K, Cotter C, Dague C, et al. Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility // American Society of Artificial Internal Organs 2016. - №62. - Р. 375–383. 13. Mehra M.R., Goldstein D.J., Uriel N., et al. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure // N Engl J Med 2018. - №378(15). - Р. 1386-1395. 14. Lim H.S., Howell N., Ranasinghe A. The Physiology of Continuous-Flow Left Ventricular Assist Devices // Journal of Cardiac Failure 2 February 2017. - Vol. 23 No 2 – P170-171. 15. Amsallem M, Mercier O., Kobayashi Y., Moneghetti K., Haddad F. A Focused Update on the Right Ventricle in Cardiovascular Disease // JACC Heart Fail 2018 -№6. –Р. 891-903. 16. Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M et al. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies // Eur J Heart Fail 2017 -№19. –Р. 926- 946. 17. Pamela S. Douglas, Blase A. Carabello, Roberto M. Lang, Leo Lopez et al. 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Transthoracic Echocardiography) and the American Society of Echocardiography // Circulation: Cardiovascular Imaging 2019. -№12. –Р. 1-68. 18. Marianna Adamo, Carlo Mario Lombardi, Marco Metra et al. Chronic and acute heart failure: from epidemiology to treatment // European Journal of Heart Failure 2019. -№21. –Р. 1879-0844 19. Nishimura RA, Otto CM, Bonow RO, Carabello BA et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology // American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014. -№63. –Р. 2438–2488. 134 20. Butler J, Fonarow GC, Zile MR, Lam CS at al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions // JACC Heart Fail 2014. -№2. –Р. 97–112. 21. Rahimi K, Bennett D, Conrad N, Williams TM et al. Risk prediction in patients with heart failure // JACC Heart Fail 2014. -№2. –Р. 440–446. 22. Ouwerkerk W , Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart-failure hospitalization in patients with heart failure // JACC Heart Fail 2014. -№2. –Р. 429–436. 23. Windecker S , Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) // Eur Heart J 2014. - №35. –Р. 2541–2619. 24. Elliott P.M., Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) // Eur Heart J 2014. -№35. –Р. 2733–2779. 25. Arbustini E , Narula N, Tavazzi L, Serio A, Grasso M, Favalli V, Bellazzi R, T ajik JABonow RD, Fuster V, Narula J. The MOGE(S) classification of cardiomyopathy for clinicians // J Am Coll Cardiol 2014. –№64. –Р. 304–318. 26. King J.B., Bress AP, Reese AD, Munger MA. Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review // Pharmacother J Hum Pharmacol Drug Ther 2015. -№35. –Р. 823–837. 27. Pitt B , Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al. Spironolactone for heart failure with preserved ejection fraction // N Engl J Med 2014. -№370. –Р. 1383–1392. 28. Sakata Y , Shiba N, Takahashi J, Miyata S, Nochioka K, Miura M, Takada T, S agaC, Shinozaki T et al. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial // Eur Heart J 2015. -№36. –Р. 915–923. 29. Turakhia MP , Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez M V, Freeman JV et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF) // Clin Cardiol 2015. –№38. –Р. 285–292. 30. Cintra FD , Leite RP, Storti LJ, Bittencourt LA, Poyares D, Castro L de S, Tufik , Paola A de. Sleep apnea and nocturnal cardiac arrhythmia: a populational study // Arq Bras Cardiol 2014. -№103. –Р. 368–374. 135 31. Gilat H , Vinker S, Buda I, Soudry E, Shani M, Bachar G. Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study // Medicine (Baltimore) 2014. -№93. –Р. e45 32. Padwal R , McAlister F a, McMurray JJ V et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data // Int J Obes 2014. -№38. –Р. 1110–1114 33. Damman K , Valente , Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis // Eur Heart J 2014. -№35. –Р. 455–469. 34. Filippatos G , Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem // жүктеу/скачать 2,5 Mb. Достарыңызбен бөлісу:
|